Cargando…
Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V(®))
Percutaneous coronary revascularization has been a mainstay in the management of coronary artery disease since its introduction in the late 1970s. Bare-metal stents and, more recently, first-generation drug-eluting stents (DES), such as sirolimus-eluting (Cypher(®)) and paclitaxel-eluting stents (Ta...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2464756/ https://www.ncbi.nlm.nih.gov/pubmed/18629361 |